Journal: Microbiology Spectrum
Article Title: Validation of serum galactomannan antigen assay for invasive pulmonary aspergillosis mortality outcome prediction
doi: 10.1128/spectrum.00651-25
Figure Lengend Snippet: Kaplan–Meier analysis of participants with validated sGMI markers. ( A ) Baseline sGMI ≥2, ( B ) Day 7 sGMI ≥1.5, ( C ) Baseline sGMI ≥2 with Day 7 sGMI ≥1.5. sGMI, serum galactomannan enzyme immunoassay optical density index.
Article Snippet: Patients with proven or probable invasive pulmonary aspergillosis (IPA) who had a serum galactomannan enzyme immunoassay optical density index (sGMI) (Platelia Aspergillus Antigen immunoassay, Bio-Rad, CA, USA) result between 2013 and 2020 at a tertiary referral center were identified.
Techniques: Enzyme-linked Immunosorbent Assay